Concepts (313)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Neoplasms | 19 | 2021 | 93 | 6.220 |
Why?
|
| Neurosurgical Procedures | 25 | 2022 | 148 | 6.030 |
Why?
|
| Epilepsy | 10 | 2018 | 69 | 3.050 |
Why?
|
| Epilepsy, Temporal Lobe | 8 | 2021 | 30 | 2.580 |
Why?
|
| Meningioma | 6 | 2020 | 17 | 2.290 |
Why?
|
| Temporal Lobe | 8 | 2021 | 90 | 2.070 |
Why?
|
| Pituitary Neoplasms | 3 | 2023 | 18 | 2.010 |
Why?
|
| Glioma | 6 | 2021 | 23 | 1.880 |
Why?
|
| Meningeal Neoplasms | 3 | 2020 | 15 | 1.740 |
Why?
|
| Neurosurgery | 7 | 2023 | 39 | 1.650 |
Why?
|
| Glioblastoma | 4 | 2021 | 13 | 1.590 |
Why?
|
| Magnetic Resonance Imaging | 23 | 2023 | 1108 | 1.430 |
Why?
|
| Humans | 66 | 2023 | 27309 | 1.280 |
Why?
|
| Brain Mapping | 3 | 2021 | 149 | 1.280 |
Why?
|
| Adenoma | 2 | 2023 | 64 | 1.260 |
Why?
|
| Electric Stimulation | 3 | 2019 | 50 | 1.240 |
Why?
|
| Adult | 32 | 2021 | 7946 | 1.130 |
Why?
|
| Postoperative Complications | 9 | 2016 | 930 | 1.120 |
Why?
|
| Hippocampus | 6 | 2021 | 275 | 1.110 |
Why?
|
| Treatment Outcome | 21 | 2023 | 3540 | 1.080 |
Why?
|
| Female | 40 | 2021 | 15334 | 1.080 |
Why?
|
| Craniotomy | 4 | 2020 | 25 | 1.030 |
Why?
|
| Electroencephalography | 8 | 2016 | 84 | 1.030 |
Why?
|
| Male | 41 | 2021 | 14887 | 1.030 |
Why?
|
| Middle Aged | 28 | 2021 | 9068 | 0.960 |
Why?
|
| Electrodes, Implanted | 2 | 2015 | 23 | 0.900 |
Why?
|
| Ganglioglioma | 3 | 2015 | 6 | 0.900 |
Why?
|
| Anterior Temporal Lobectomy | 3 | 2013 | 9 | 0.890 |
Why?
|
| Deep Brain Stimulation | 4 | 2021 | 40 | 0.820 |
Why?
|
| Lumbar Vertebrae | 3 | 2018 | 391 | 0.800 |
Why?
|
| Endoscopy | 3 | 2023 | 182 | 0.780 |
Why?
|
| Monitoring, Intraoperative | 2 | 2022 | 37 | 0.770 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2022 | 8 | 0.770 |
Why?
|
| Implantable Neurostimulators | 3 | 2017 | 8 | 0.710 |
Why?
|
| Monitoring, Physiologic | 2 | 2014 | 70 | 0.700 |
Why?
|
| Empty Sella Syndrome | 1 | 2020 | 4 | 0.690 |
Why?
|
| Sphenoid Bone | 2 | 2020 | 5 | 0.690 |
Why?
|
| Internship and Residency | 4 | 2021 | 215 | 0.690 |
Why?
|
| Adolescent | 13 | 2021 | 2185 | 0.680 |
Why?
|
| Cerebral Cortex | 3 | 2017 | 154 | 0.660 |
Why?
|
| Sclerosis | 3 | 2017 | 69 | 0.630 |
Why?
|
| Emergency Medical Services | 2 | 2011 | 32 | 0.630 |
Why?
|
| Young Adult | 11 | 2021 | 2032 | 0.620 |
Why?
|
| Superior Sagittal Sinus | 1 | 2019 | 2 | 0.620 |
Why?
|
| Intraoperative Complications | 2 | 2018 | 66 | 0.620 |
Why?
|
| Hydrocephalus | 2 | 2021 | 16 | 0.620 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 218 | 0.620 |
Why?
|
| Epilepsy, Complex Partial | 3 | 2017 | 5 | 0.610 |
Why?
|
| Retrospective Studies | 14 | 2021 | 3551 | 0.610 |
Why?
|
| Incidental Findings | 1 | 2018 | 14 | 0.580 |
Why?
|
| Dura Mater | 1 | 2018 | 19 | 0.570 |
Why?
|
| Cerebral Hemorrhage | 1 | 2018 | 109 | 0.530 |
Why?
|
| Brain Waves | 1 | 2016 | 5 | 0.530 |
Why?
|
| Learning Curve | 1 | 2016 | 19 | 0.510 |
Why?
|
| Nasal Cavity | 1 | 2016 | 33 | 0.510 |
Why?
|
| Cranial Fossa, Middle | 2 | 2019 | 6 | 0.490 |
Why?
|
| Diagnosis, Differential | 5 | 2015 | 350 | 0.490 |
Why?
|
| Malformations of Cortical Development | 1 | 2015 | 2 | 0.490 |
Why?
|
| Encephalocele | 2 | 2019 | 26 | 0.490 |
Why?
|
| Amygdala | 3 | 2014 | 42 | 0.480 |
Why?
|
| Aged | 13 | 2021 | 9119 | 0.470 |
Why?
|
| Subdural Space | 1 | 2015 | 3 | 0.470 |
Why?
|
| Astrocytoma | 3 | 2011 | 18 | 0.470 |
Why?
|
| Paralysis | 1 | 2015 | 15 | 0.470 |
Why?
|
| Neoplasm Grading | 4 | 2019 | 55 | 0.470 |
Why?
|
| Scalp | 1 | 2015 | 6 | 0.470 |
Why?
|
| Humeral Fractures | 1 | 2015 | 22 | 0.460 |
Why?
|
| Boxing | 1 | 2014 | 2 | 0.460 |
Why?
|
| Hematoma, Subdural, Spinal | 1 | 2014 | 3 | 0.460 |
Why?
|
| Lymphoma | 1 | 2015 | 36 | 0.460 |
Why?
|
| Cysts | 1 | 2014 | 14 | 0.450 |
Why?
|
| Essential Tremor | 1 | 2014 | 5 | 0.450 |
Why?
|
| Intracranial Hemorrhages | 1 | 2014 | 14 | 0.440 |
Why?
|
| Neurilemmoma | 1 | 2014 | 16 | 0.440 |
Why?
|
| Professional Competence | 1 | 2014 | 38 | 0.440 |
Why?
|
| Papilloma, Choroid Plexus | 1 | 2014 | 2 | 0.440 |
Why?
|
| Clinical Competence | 1 | 2016 | 210 | 0.430 |
Why?
|
| Cerebellopontine Angle | 1 | 2014 | 5 | 0.430 |
Why?
|
| Spinal Neoplasms | 1 | 2014 | 37 | 0.430 |
Why?
|
| Psychophysiologic Disorders | 1 | 2013 | 7 | 0.430 |
Why?
|
| Respiration Disorders | 1 | 2013 | 4 | 0.430 |
Why?
|
| Arnold-Chiari Malformation | 1 | 2013 | 5 | 0.430 |
Why?
|
| General Surgery | 1 | 2014 | 55 | 0.430 |
Why?
|
| Syncope | 1 | 2013 | 6 | 0.430 |
Why?
|
| Aged, 80 and over | 8 | 2021 | 4841 | 0.420 |
Why?
|
| Anticoagulants | 1 | 2014 | 88 | 0.420 |
Why?
|
| Panic Disorder | 1 | 2013 | 134 | 0.400 |
Why?
|
| Lasers, Gas | 1 | 2012 | 1 | 0.380 |
Why?
|
| Cotton Fiber | 1 | 2012 | 1 | 0.380 |
Why?
|
| Granuloma, Foreign-Body | 1 | 2012 | 3 | 0.380 |
Why?
|
| Corpus Callosum | 1 | 2012 | 13 | 0.380 |
Why?
|
| Headache | 2 | 2011 | 38 | 0.370 |
Why?
|
| Gliosarcoma | 1 | 2011 | 2 | 0.360 |
Why?
|
| Neural Stem Cells | 1 | 2011 | 13 | 0.360 |
Why?
|
| Oligodendroglioma | 1 | 2011 | 6 | 0.360 |
Why?
|
| Child, Preschool | 4 | 2016 | 624 | 0.360 |
Why?
|
| Functional Laterality | 4 | 2018 | 62 | 0.360 |
Why?
|
| Follow-Up Studies | 6 | 2018 | 1807 | 0.360 |
Why?
|
| Tomography, X-Ray Computed | 7 | 2019 | 667 | 0.360 |
Why?
|
| Parietal Lobe | 2 | 2014 | 17 | 0.350 |
Why?
|
| Radiosurgery | 3 | 2019 | 37 | 0.350 |
Why?
|
| Central Nervous System Diseases | 1 | 2011 | 17 | 0.350 |
Why?
|
| Optic Nerve | 2 | 2020 | 7 | 0.350 |
Why?
|
| Manikins | 1 | 2010 | 3 | 0.350 |
Why?
|
| Patient Simulation | 1 | 2010 | 11 | 0.350 |
Why?
|
| Seizures | 5 | 2018 | 70 | 0.340 |
Why?
|
| Neurosurgeons | 3 | 2021 | 9 | 0.340 |
Why?
|
| Cerebrospinal Fluid Leak | 3 | 2019 | 24 | 0.320 |
Why?
|
| Movement Disorders | 1 | 2010 | 67 | 0.320 |
Why?
|
| Preoperative Care | 3 | 2017 | 121 | 0.320 |
Why?
|
| Prognosis | 3 | 2021 | 808 | 0.320 |
Why?
|
| Critical Care | 1 | 2010 | 122 | 0.310 |
Why?
|
| Physicians | 1 | 2011 | 126 | 0.310 |
Why?
|
| Spinal Diseases | 1 | 2010 | 113 | 0.300 |
Why?
|
| Encephalomyelitis, Acute Disseminated | 1 | 2008 | 4 | 0.300 |
Why?
|
| Brain | 6 | 2017 | 1648 | 0.300 |
Why?
|
| Hemostasis, Surgical | 1 | 2008 | 15 | 0.300 |
Why?
|
| Collagen | 1 | 2008 | 86 | 0.290 |
Why?
|
| Electrodiagnosis | 1 | 2008 | 6 | 0.290 |
Why?
|
| Geography | 1 | 2008 | 18 | 0.290 |
Why?
|
| Patient Transfer | 1 | 2008 | 26 | 0.290 |
Why?
|
| Epidural Space | 1 | 2008 | 20 | 0.290 |
Why?
|
| White Matter | 2 | 2021 | 137 | 0.270 |
Why?
|
| Academic Medical Centers | 1 | 2008 | 133 | 0.270 |
Why?
|
| Child | 4 | 2016 | 1269 | 0.250 |
Why?
|
| Nervous System Diseases | 1 | 2008 | 121 | 0.250 |
Why?
|
| Cranial Sinuses | 1 | 2005 | 2 | 0.240 |
Why?
|
| Wounds, Penetrating | 1 | 2005 | 7 | 0.240 |
Why?
|
| Neurologic Examination | 3 | 2014 | 101 | 0.230 |
Why?
|
| Munchausen Syndrome | 1 | 2004 | 1 | 0.230 |
Why?
|
| Intraoperative Neurophysiological Monitoring | 2 | 2015 | 7 | 0.230 |
Why?
|
| Immunohistochemistry | 3 | 2015 | 375 | 0.210 |
Why?
|
| Allostasis | 1 | 2023 | 4 | 0.210 |
Why?
|
| Chronic Disease | 3 | 2015 | 425 | 0.210 |
Why?
|
| Radiography | 2 | 2015 | 616 | 0.190 |
Why?
|
| Radiotherapy | 2 | 2021 | 33 | 0.190 |
Why?
|
| Evoked Potentials, Motor | 1 | 2022 | 10 | 0.190 |
Why?
|
| Electromyography | 1 | 2022 | 72 | 0.190 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2021 | 8 | 0.180 |
Why?
|
| Laparotomy | 1 | 2021 | 19 | 0.180 |
Why?
|
| Karnofsky Performance Status | 1 | 2021 | 3 | 0.180 |
Why?
|
| Age Factors | 2 | 2021 | 779 | 0.180 |
Why?
|
| Drug Therapy | 1 | 2021 | 6 | 0.180 |
Why?
|
| Drug Resistant Epilepsy | 1 | 2021 | 11 | 0.180 |
Why?
|
| Multimodal Imaging | 1 | 2021 | 28 | 0.170 |
Why?
|
| Optic Chiasm | 1 | 2020 | 3 | 0.170 |
Why?
|
| Skull | 2 | 2015 | 21 | 0.170 |
Why?
|
| Skull Base | 1 | 2020 | 35 | 0.170 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2021 | 177 | 0.170 |
Why?
|
| Survival Analysis | 1 | 2021 | 261 | 0.170 |
Why?
|
| Medicare | 1 | 2021 | 123 | 0.170 |
Why?
|
| Combined Modality Therapy | 1 | 2021 | 306 | 0.160 |
Why?
|
| Sella Turcica | 1 | 2019 | 4 | 0.160 |
Why?
|
| Cohort Studies | 3 | 2021 | 1903 | 0.160 |
Why?
|
| Surgical Wound | 1 | 2019 | 10 | 0.160 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2019 | 30 | 0.160 |
Why?
|
| Neuroimaging | 2 | 2018 | 129 | 0.160 |
Why?
|
| Semicircular Canals | 1 | 2019 | 5 | 0.160 |
Why?
|
| Temporal Bone | 1 | 2019 | 9 | 0.160 |
Why?
|
| Laparoscopy | 1 | 2021 | 188 | 0.160 |
Why?
|
| Databases, Factual | 1 | 2021 | 352 | 0.150 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 201 | 0.150 |
Why?
|
| Wound Healing | 1 | 2019 | 159 | 0.150 |
Why?
|
| Channelopathies | 1 | 2018 | 6 | 0.150 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2018 | 9 | 0.150 |
Why?
|
| Hyperpolarization-Activated Cyclic Nucleotide-Gated Channels | 1 | 2018 | 11 | 0.150 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 1380 | 0.150 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 46 | 0.140 |
Why?
|
| Cerebral Ventricles | 1 | 2018 | 19 | 0.140 |
Why?
|
| Pyramidal Cells | 1 | 2018 | 35 | 0.140 |
Why?
|
| Neuronal Plasticity | 1 | 2018 | 48 | 0.140 |
Why?
|
| United States | 4 | 2021 | 2078 | 0.140 |
Why?
|
| Hand | 1 | 2018 | 40 | 0.140 |
Why?
|
| Laminectomy | 1 | 2018 | 42 | 0.140 |
Why?
|
| Comorbidity | 2 | 2021 | 488 | 0.140 |
Why?
|
| Circle of Willis | 1 | 2017 | 6 | 0.140 |
Why?
|
| Prosthesis Implantation | 1 | 2017 | 27 | 0.130 |
Why?
|
| Epilepsies, Partial | 1 | 2017 | 14 | 0.130 |
Why?
|
| Orbital Cellulitis | 1 | 2016 | 1 | 0.130 |
Why?
|
| Models, Neurological | 1 | 2017 | 27 | 0.130 |
Why?
|
| Empyema, Subdural | 1 | 2016 | 2 | 0.130 |
Why?
|
| Sensory Thresholds | 1 | 2016 | 23 | 0.130 |
Why?
|
| Hypopituitarism | 1 | 2016 | 1 | 0.130 |
Why?
|
| Diabetes Insipidus | 1 | 2016 | 2 | 0.130 |
Why?
|
| Visual Fields | 1 | 2016 | 3 | 0.130 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2015 | 13 | 0.120 |
Why?
|
| Ependymoma | 1 | 2015 | 17 | 0.120 |
Why?
|
| Sleep Apnea, Central | 1 | 2015 | 30 | 0.120 |
Why?
|
| Intracranial Pressure | 1 | 2015 | 13 | 0.120 |
Why?
|
| Postoperative Hemorrhage | 1 | 2015 | 25 | 0.110 |
Why?
|
| Drainage | 1 | 2015 | 44 | 0.110 |
Why?
|
| Blood Coagulation Tests | 1 | 2014 | 12 | 0.110 |
Why?
|
| Rivaroxaban | 1 | 2014 | 6 | 0.110 |
Why?
|
| Dabigatran | 1 | 2014 | 6 | 0.110 |
Why?
|
| Antidotes | 1 | 2014 | 4 | 0.110 |
Why?
|
| Pyridones | 1 | 2014 | 12 | 0.110 |
Why?
|
| International Normalized Ratio | 1 | 2014 | 19 | 0.110 |
Why?
|
| Craniocerebral Trauma | 1 | 2014 | 7 | 0.110 |
Why?
|
| Occipital Lobe | 1 | 2014 | 6 | 0.110 |
Why?
|
| Head | 1 | 2014 | 24 | 0.110 |
Why?
|
| Length of Stay | 1 | 2016 | 321 | 0.110 |
Why?
|
| Surgical Wound Infection | 1 | 2015 | 87 | 0.110 |
Why?
|
| Dominance, Cerebral | 1 | 2013 | 16 | 0.110 |
Why?
|
| Mutation | 1 | 2015 | 353 | 0.110 |
Why?
|
| Frontal Lobe | 1 | 2014 | 82 | 0.110 |
Why?
|
| Cough | 1 | 2013 | 9 | 0.110 |
Why?
|
| Biopsy | 1 | 2014 | 201 | 0.110 |
Why?
|
| Pyrazoles | 1 | 2014 | 61 | 0.110 |
Why?
|
| Aquaporin 4 | 1 | 2012 | 6 | 0.100 |
Why?
|
| Aquaporins | 1 | 2012 | 7 | 0.100 |
Why?
|
| Low Back Pain | 1 | 2014 | 133 | 0.100 |
Why?
|
| Escherichia coli Proteins | 1 | 2012 | 11 | 0.100 |
Why?
|
| Neuromyelitis Optica | 1 | 2012 | 6 | 0.100 |
Why?
|
| Cervical Vertebrae | 2 | 2013 | 288 | 0.100 |
Why?
|
| Granuloma, Giant Cell | 1 | 2012 | 1 | 0.100 |
Why?
|
| Suction | 1 | 2012 | 42 | 0.090 |
Why?
|
| Disease Progression | 1 | 2014 | 672 | 0.090 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2012 | 164 | 0.090 |
Why?
|
| Tumor Burden | 1 | 2011 | 25 | 0.090 |
Why?
|
| Brain Edema | 1 | 2011 | 18 | 0.090 |
Why?
|
| Valproic Acid | 1 | 2011 | 14 | 0.090 |
Why?
|
| Spinal Fusion | 1 | 2018 | 464 | 0.090 |
Why?
|
| Age of Onset | 1 | 2011 | 95 | 0.090 |
Why?
|
| Anticonvulsants | 1 | 2011 | 56 | 0.090 |
Why?
|
| Acute Disease | 1 | 2011 | 180 | 0.090 |
Why?
|
| Intraoperative Period | 1 | 2010 | 24 | 0.090 |
Why?
|
| Gliosis | 1 | 2010 | 7 | 0.080 |
Why?
|
| Equipment Design | 1 | 2010 | 136 | 0.080 |
Why?
|
| Teaching | 1 | 2010 | 51 | 0.080 |
Why?
|
| Education, Medical | 1 | 2010 | 46 | 0.080 |
Why?
|
| Learning | 1 | 2010 | 72 | 0.080 |
Why?
|
| Socioeconomic Factors | 1 | 2011 | 305 | 0.080 |
Why?
|
| Education, Medical, Graduate | 2 | 2021 | 79 | 0.080 |
Why?
|
| Students, Medical | 1 | 2010 | 58 | 0.080 |
Why?
|
| Diagnostic Imaging | 1 | 2010 | 83 | 0.080 |
Why?
|
| Positron-Emission Tomography | 1 | 2010 | 87 | 0.080 |
Why?
|
| Educational Status | 1 | 2011 | 289 | 0.080 |
Why?
|
| Hematoma, Subdural, Intracranial | 1 | 2008 | 2 | 0.080 |
Why?
|
| Blood Patch, Epidural | 1 | 2008 | 7 | 0.080 |
Why?
|
| Subdural Effusion | 1 | 2008 | 7 | 0.080 |
Why?
|
| Electrodes | 1 | 2008 | 14 | 0.070 |
Why?
|
| Pinealoma | 1 | 2007 | 1 | 0.070 |
Why?
|
| Midwestern United States | 1 | 2008 | 50 | 0.070 |
Why?
|
| Pineal Gland | 1 | 2007 | 4 | 0.070 |
Why?
|
| Carcinoma, Papillary | 1 | 2007 | 25 | 0.070 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 903 | 0.070 |
Why?
|
| Syringomyelia | 1 | 2007 | 7 | 0.070 |
Why?
|
| Shoulder Pain | 1 | 2007 | 58 | 0.070 |
Why?
|
| Stroke | 1 | 2010 | 269 | 0.070 |
Why?
|
| Alzheimer Disease | 1 | 2018 | 2119 | 0.060 |
Why?
|
| Surveys and Questionnaires | 1 | 2011 | 1156 | 0.060 |
Why?
|
| Construction Materials | 1 | 2005 | 2 | 0.060 |
Why?
|
| Fascia | 1 | 2005 | 9 | 0.060 |
Why?
|
| Gene Expression Profiling | 2 | 2003 | 143 | 0.060 |
Why?
|
| Surgery, Computer-Assisted | 2 | 2017 | 51 | 0.050 |
Why?
|
| RNA, Neoplasm | 1 | 2003 | 13 | 0.050 |
Why?
|
| Prospective Studies | 1 | 2008 | 1792 | 0.050 |
Why?
|
| Models, Theoretical | 1 | 2002 | 84 | 0.050 |
Why?
|
| Gene Expression | 1 | 2002 | 201 | 0.050 |
Why?
|
| Peritoneum | 1 | 2021 | 16 | 0.040 |
Why?
|
| Fellowships and Scholarships | 1 | 2021 | 37 | 0.040 |
Why?
|
| Accreditation | 1 | 2020 | 15 | 0.040 |
Why?
|
| Hearing Loss | 1 | 2019 | 16 | 0.040 |
Why?
|
| Curriculum | 1 | 2020 | 140 | 0.040 |
Why?
|
| Smoking | 1 | 2019 | 183 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2018 | 26 | 0.040 |
Why?
|
| Obesity | 1 | 2021 | 309 | 0.040 |
Why?
|
| Action Potentials | 1 | 2018 | 85 | 0.040 |
Why?
|
| Animals | 2 | 2018 | 3682 | 0.040 |
Why?
|
| Mice, Transgenic | 1 | 2018 | 225 | 0.030 |
Why?
|
| Neuronavigation | 1 | 2017 | 4 | 0.030 |
Why?
|
| Stereotaxic Techniques | 1 | 2017 | 15 | 0.030 |
Why?
|
| Intraoperative Care | 1 | 2017 | 42 | 0.030 |
Why?
|
| Exophthalmos | 1 | 2016 | 1 | 0.030 |
Why?
|
| Streptococcus milleri Group | 1 | 2016 | 1 | 0.030 |
Why?
|
| Prevalence | 1 | 2018 | 458 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2017 | 61 | 0.030 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2017 | 79 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 606 | 0.030 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2015 | 51 | 0.030 |
Why?
|
| Sinusitis | 1 | 2016 | 164 | 0.030 |
Why?
|
| Medical Errors | 1 | 2014 | 27 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 270 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 380 | 0.030 |
Why?
|
| Cytotoxicity Tests, Immunologic | 1 | 2012 | 7 | 0.020 |
Why?
|
| Structural Homology, Protein | 1 | 2012 | 5 | 0.020 |
Why?
|
| Cross Reactions | 1 | 2012 | 9 | 0.020 |
Why?
|
| Postoperative Period | 1 | 2014 | 334 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2012 | 67 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2012 | 154 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2012 | 194 | 0.020 |
Why?
|
| Rabbits | 1 | 2012 | 180 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 183 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2012 | 80 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2012 | 527 | 0.020 |
Why?
|
| Risk Factors | 1 | 2017 | 2335 | 0.020 |
Why?
|
| Intracranial Hypotension | 1 | 2008 | 5 | 0.020 |
Why?
|
| Aging | 1 | 2018 | 1555 | 0.020 |
Why?
|
| Mice | 1 | 2012 | 1450 | 0.020 |
Why?
|
| Diplopia | 1 | 2007 | 3 | 0.020 |
Why?
|
| Nystagmus, Pathologic | 1 | 2007 | 3 | 0.020 |
Why?
|
| Recurrence | 1 | 2008 | 309 | 0.020 |
Why?
|
| Neuropsychological Tests | 1 | 2011 | 1198 | 0.020 |
Why?
|
| Football | 1 | 2007 | 38 | 0.020 |
Why?
|
| Baseball | 1 | 2007 | 103 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 60 | 0.010 |
Why?
|
| Multigene Family | 1 | 2002 | 9 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2002 | 146 | 0.010 |
Why?
|
| Phenotype | 1 | 2003 | 313 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2003 | 589 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2003 | 290 | 0.010 |
Why?
|
| Algorithms | 1 | 2003 | 352 | 0.010 |
Why?
|
| Signal Transduction | 1 | 2003 | 455 | 0.010 |
Why?
|